secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2022-06-07T23:59:59+00:00
Accession:  0001437749-22-014518
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo shareholders approve increase in authorized shares to 550M and authorize reverse stock split
--------------------------------------------------------------------------------

- Authorized common shares increased from 400M to 550M, effective June 7, 2022.
- Board authorized to implement a reverse stock split at a ratio between 1:4 and 1:25 at its discretion.
- All seven director nominees elected; advisory say-on-pay passed with 84.3M for, 9.8M against.
- Ratification of Haskell & White LLP as auditor for FY2022 approved with 151.2M for.
- Reverse split proposal passed with 136.2M for, 16.7M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/0001437749-22-014518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/blgo20220606_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-014518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer